Cargando…
JAK/STAT: Why choose a classical or an alternative pathway when you can have both?
A subset of cytokines triggers the JAK‐STAT pathway to exert various functions such as the induction of inflammation and immune responses. The receptors for these cytokines are dimers/trimers of transmembrane proteins devoid of intracellular kinase activity. Instead, they rely on Janus kinases (JAKs...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980962/ https://www.ncbi.nlm.nih.gov/pubmed/35238133 http://dx.doi.org/10.1111/jcmm.17168 |
_version_ | 1784681506165227520 |
---|---|
author | Puigdevall, Léna Michiels, Camille Stewardson, Clara Dumoutier, Laure |
author_facet | Puigdevall, Léna Michiels, Camille Stewardson, Clara Dumoutier, Laure |
author_sort | Puigdevall, Léna |
collection | PubMed |
description | A subset of cytokines triggers the JAK‐STAT pathway to exert various functions such as the induction of inflammation and immune responses. The receptors for these cytokines are dimers/trimers of transmembrane proteins devoid of intracellular kinase activity. Instead, they rely on Janus kinases (JAKs) for signal transduction. Classical JAK‐STAT signalling involves phosphorylation of cytokine receptors' intracellular tyrosines, which subsequently serve as docking sites for the recruitment and activation of STATs. However, there is evidence to show that several cytokine receptors also use a noncanonical, receptor tyrosine‐independent path to induce activation of STAT proteins. We identified two main alternative modes of STAT activation. The first involves an association between a tyrosine‐free region of the cytokine receptor and STATs, while the second seems to depend on a direct interaction between JAK and STAT proteins. We were able to identify the use of noncanonical mechanisms by almost a dozen cytokine receptors, suggesting they have some importance. These alternative pathways and the receptors that employ them are discussed in this review. |
format | Online Article Text |
id | pubmed-8980962 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89809622022-04-11 JAK/STAT: Why choose a classical or an alternative pathway when you can have both? Puigdevall, Léna Michiels, Camille Stewardson, Clara Dumoutier, Laure J Cell Mol Med Review A subset of cytokines triggers the JAK‐STAT pathway to exert various functions such as the induction of inflammation and immune responses. The receptors for these cytokines are dimers/trimers of transmembrane proteins devoid of intracellular kinase activity. Instead, they rely on Janus kinases (JAKs) for signal transduction. Classical JAK‐STAT signalling involves phosphorylation of cytokine receptors' intracellular tyrosines, which subsequently serve as docking sites for the recruitment and activation of STATs. However, there is evidence to show that several cytokine receptors also use a noncanonical, receptor tyrosine‐independent path to induce activation of STAT proteins. We identified two main alternative modes of STAT activation. The first involves an association between a tyrosine‐free region of the cytokine receptor and STATs, while the second seems to depend on a direct interaction between JAK and STAT proteins. We were able to identify the use of noncanonical mechanisms by almost a dozen cytokine receptors, suggesting they have some importance. These alternative pathways and the receptors that employ them are discussed in this review. John Wiley and Sons Inc. 2022-03-03 2022-04 /pmc/articles/PMC8980962/ /pubmed/35238133 http://dx.doi.org/10.1111/jcmm.17168 Text en © 2022 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Puigdevall, Léna Michiels, Camille Stewardson, Clara Dumoutier, Laure JAK/STAT: Why choose a classical or an alternative pathway when you can have both? |
title | JAK/STAT: Why choose a classical or an alternative pathway when you can have both? |
title_full | JAK/STAT: Why choose a classical or an alternative pathway when you can have both? |
title_fullStr | JAK/STAT: Why choose a classical or an alternative pathway when you can have both? |
title_full_unstemmed | JAK/STAT: Why choose a classical or an alternative pathway when you can have both? |
title_short | JAK/STAT: Why choose a classical or an alternative pathway when you can have both? |
title_sort | jak/stat: why choose a classical or an alternative pathway when you can have both? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980962/ https://www.ncbi.nlm.nih.gov/pubmed/35238133 http://dx.doi.org/10.1111/jcmm.17168 |
work_keys_str_mv | AT puigdevalllena jakstatwhychooseaclassicaloranalternativepathwaywhenyoucanhaveboth AT michielscamille jakstatwhychooseaclassicaloranalternativepathwaywhenyoucanhaveboth AT stewardsonclara jakstatwhychooseaclassicaloranalternativepathwaywhenyoucanhaveboth AT dumoutierlaure jakstatwhychooseaclassicaloranalternativepathwaywhenyoucanhaveboth |